About Nimesh Jaiswal
Nimesh Jaiswal's fervent interest in analyzing and interpreting financial data led him to a career as a financial analyst and journalist. The importance of financial statements in driving a stock’s price is the key approach that he follows while advising investors in his articles.
Nimesh majored in accounting and finance in college and is currently pursuing a CMA (Cost & Management Accountant) program.
Recent Articles By Nimesh Jaiswal
3 International Growth Stocks With Even More Upside
Amid the severe market volatility in the United States, it could be wise to invest in quality international stocks to dodge the volatility in the domestic stock market. Global stocks Weibo (WB), Shoprite (SRGHY), and Fuwei (FFHL) could be solid additions to your portfolio, given their solid growth attributes.
Is Unique Fabricating a Good Motor Vehicle Parts Stock to Own?
Motor vehicle part company Unique Fabricating (UFAB) reported improved top-line and bottom-line numbers in the second quarter. While the stock has outperformed the broader market over the past month, can it maintain the momentum? Read on.
4 Tech ETFs Poised to Make New Highs as the Market Rally Resumes
While potential interest rate hikes next year could mar the tech industry’s growth, the continued digital transformation makes the industry’s long-term prospects bright. So, investors looking to capitalize on the industry’s growth in a relatively less risky way could bet on popular Tech ETFs such as the Vanguard Information Technology Index Fund ETF Shares (VGT), First Trust Dow Jones Internet Index Fund (FDN), Global X Cloud Computing ETF (CLOU), and Innovator ETFs Trust - Innovator IBD 50 ETF (FFTY).
ZK International vs. Jiayin Group: Which NFT Stock is a Better Investment?
While NFT trading volume has declined this month, investing in digital collectibles is not a fad. Jiayin (JFIN) and ZK International (ZKIN) are two stocks that give investors exposure to this growing market. But which of these stocks is a better buy now? Read more to find out.
2 Dow Jones Stocks to Buy in October, 2 to Avoid
The Dow Jones Industrial Average has had a positive tailwind as the economy gradually reopens and companies grow earnings. However, they do face some headwinds as the coronavirus cases remain stubbornly high and inflationary pressures persist. Given these factors, it could be worth betting on Dow stocks Johnson & Johnson (JNJ) and Cisco (CSCO) while NIKE (NKE) and The Boeing Company (BA) are best avoided for now.
Is Aethlon Medical a Good Healthtech Company to Own?
Therapeutic technology company Aethlon Medical (AEMD) has been making several positive developments, but its losses widened in the second quarter. So, let’s find out if it is wise to bet on the stock now.
Grab These 4 Buy-Rated Shipping Stocks Racing Higher
Even though a resurgence of COVID-19 cases hinders the shipping industry’s growth, the demand for shipping has been rising rapidly with industries reopening across the globe. So, it could be wise to scoop up soaring shipping stocks such as ZIM Integrated (ZIM), Danaos (DAC), Euroseas (ESEA), and EuroDry (EDRY).
Should You Buy the Dip in Walt Disney Co.?
Entertainment giant Walt Disney’s (DIS) shares have dipped in price since CEO Bob Chapek acknowledged recently that various challenges will lead to fewer new Disney+ users than expected. However, can the stock rebound by leveraging its broad portfolio of products and services? Let’s find out.
4 No-Brainer Pharmaceutical Stocks to Buy in October
Most companies in the pharmaceutical space have been the subject of immense investor attention since the onset of the COVID-19 pandemic last year. The demand for their products and services is expected to increase in the coming months due to an aging population and increasing demand for therapies for chronic diseases. So, we think it could be wise to bet on pharma stocks Johnson & Johnson (JNJ), AstraZeneca (AZN), GlaxoSmithKline (GSK), and Astellas Pharma (ALPMY). These names possess solid fundamentals and are rated ‘Strong Buy’ in our proprietary rating system. So, read on for a closer examination.